← Open Payments lookup

KHADIJA HAMISI: Open Payments

NPI 1225360498 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,755 in 86 payments from 9 companies in 2025. Trend: 2023 $1,952 · 2024 $2,488 · 2025 $2,755

Food & beverage: $1,556Consulting: $1,088Education: $111
CompanyPaymentsAmount
Otsuka Pharmaceutical Development & Commercialization, Inc.1$1,088
Alkermes, Inc.29$467
Bausch Health US, LLC16$349
Teva Pharmaceuticals USA, Inc.11$275
ABBVIE INC.8$182
Otsuka America Pharmaceutical, Inc.9$181
E.R. Squibb & Sons, L.L.C.9$165
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$32
Janssen Pharmaceuticals, Inc1$18

Products named: ABILIFY ASIMTUFII, ARISTADA, APLENZIN, VRAYLAR, COBENFY, UZEDY, ABILIFY MAINTENA, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.